Seattlebased

Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies

by
Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies

Shape CEO Francois Vigneault. (Shape photo) Shape Therapeutics, a Seattle preclinical biotech company developing RNA editing and gene therapy technologies, has raised $ 112 million. The company’s RNA editing technologies come from the laboratory of co-founder Prashant Mali, a bio-engineer at the University of California, San Diego, who sits on Shape’s scientific advisory board. Shape … Read more

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

by
Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology

Icosavax creates virus-like particles using technology licensed from the University of Washington’s Institute for Protein Design. (Icosavax photo) Seattle-based Icosavax filed for an IPO just four years after it started at the University of Washington. The company, a spin-out of the UW’s Institute for Protein Design, develops vaccines that resemble naturally occurring viruses. Icosavax initiated … Read more